Get the Stockscreener App
3.12
0.95%
-0.03
After Hours:
3.13
0.010
+0.32%
Cerus Corp stock is traded at $3.12, with a volume of 1.73M.
It is down -0.95% in the last 24 hours and up +21.88% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$3.15
Open:
$3.15
24h Volume:
1.73M
Relative Volume:
0.67
Market Cap:
$625.15M
Revenue:
$216.56M
Net Income/Loss:
$-9.57M
P/E Ratio:
-62.78
EPS:
-0.0497
Net Cash Flow:
$-1.22M
1W Performance:
-1.27%
1M Performance:
+21.88%
6M Performance:
+51.46%
1Y Performance:
+101.29%
1-Day Range:
$3.02
$3.165
1-Week Range:
$3.02
$3.4698
52-Week Range:
$1.15
$3.4698
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
3.12 | 625.15M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - ad-hoc-news.de
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
Cerus CFO Kevin Green sells $99,105 in CERS shares - Investing.com
Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes - Investing.com
Cerus CEO William Greenman sells $299,937 in common stock - Investing.com
Form 4 Cerus Corporation For: 2 July By Investing.com - Investing.com Canada
Cerus CEO William Greenman sells $299,937 in common stock By Investing.com - Investing.com Canada
Cerus (CERS) CFO logs tax-related share sale and new stock grant - Stock Titan
Cerus (CERS) COO granted RSUs, performance rights and sells shares - Stock Titan
Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant - Stock Titan
CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant - Stock Titan
Cerus Corp (CERS) Institutional Confidence - TradingKey
Cerus StockFriday sector check and transfusion focus - AD HOC NEWS
CERUS CORP (CERS) Stock Chart - ChartMill
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus Corp (CERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus takes INTERCEPT blood system data to global transfusion congress - Stock Titan
Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M - Insider Monkey
5 Best Genomics Stocks to Buy According to Analysts - Insider Monkey
Cerus Corporation (NASDAQ:CERS) Sees Significant Decrease in Short Interest - MarketBeat
Cerus Corp director Eric Bjerkholt sells $53,180 in stock By Investing.com - Investing.com Australia
Director Eric Bjerkholt Sells 20,454 Shares of Cerus Corp (CERS) - GuruFocus
Cerus Corp director Eric Bjerkholt sells $53,180 in stock - Investing.com UK
Cerus Corp (CERS) director sells 20,454 common shares in open-market trade - Stock Titan
[144] CERUS CORP SEC Filing - Stock Titan
CERS Secures $110M Debt Facility for Enhanced Financial Flexibil - GuruFocus
Cerus Refinances Credit Facilities: $65 Million Term Loan and $30 Million Revolver With MidCap - TradingView
Cerus (NASDAQ: CERS) refinances $65M term loan and $30M revolver - Stock Titan
Cerus secures $110 million debt facility with MidCap Financial By Investing.com - Investing.com Canada
Cerus secures $110 million debt facility with MidCap Financial - Investing.com
$110M refinancing expected to save Cerus up to $3.5M a year - Stock Titan
CERS News | CERUS CORP (NASDAQ:CERS) - ChartMill
Should I buy Cerus (CERS) - Zacks Investment Research
Cerus (NASDAQ: CERS) holders back equity plan, board and auditors - Stock Titan
Cerus COO Vivek Jayaraman sells $50,001 in company stock By Investing.com - Investing.com Nigeria
Cerus COO Vivek Jayaraman sells $50,001 in company stock - Investing.com
Cerus (NASDAQ: CERS) director granted 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director receives 60,000 RSUs under 2024 equity plan - Stock Titan
Cerus (CERS) director Jami Nachtsheim awarded 60,000 RSUs, lifting holdings to 268,362 shares - Stock Titan
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jayaraman Vivek K | Chief Operating Officer |
Jun 30 '26 |
Sale |
2.94 |
42,359 |
124,658 |
1,694,348 |
| Jensen Chrystal | Chief Legal Officer |
Jun 30 '26 |
Sale |
2.94 |
24,329 |
71,598 |
966,657 |
| Greenman William Mariner | President and CEO |
Jun 30 '26 |
Sale |
2.94 |
101,919 |
299,937 |
5,053,036 |
| BJERKHOLT ERIC | Director |
Jun 09 '26 |
Sale |
2.60 |
20,454 |
53,180 |
261,679 |
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):